Skip to ContentSkip to Navigation
About us Latest news News News articles

Floris de Lange - Shaping perception by expectation and attention

14 February 2012

Perception is not simply a passive process of accumulation of sensory evidence, but it is strongly shaped by internal brain states, which incorporate our goals, attention, expectations, and knowledge about the world. In my talk, I will focus on how expectation shapes perception, in terms of brain and behavior. I will contrast two views of how expectation influences perception: by changing the weight of sensory evidence on a perceptual decision (cf. “taking the statements of the suspect with a grain of salt”), or by changing the evidence itself (cf. “planting evidence on the suspect”).

I will highlight recent neuroimaging data (MEG and fMRI) and multivariate methods (MVPA) that show how stimulus expectations reduce neural activity in early sensory cortex, but boost the amount of information that can be “read out” from these areas. In conclusion, I will argue that the brain both “plants” and “weights” sensory evidence during perceptual decision-making.

For more information: http://www.predatt.com

Last modified:10 February 2021 2.57 p.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.